Dr. Matthew Lloyd is a Senior Lecturer at Department of Pharmacy & Pharmacology, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) of University of Bath, United Kingdom. He completed his Bachelor of Science at the University of Leicester, and his Doctor of Philosophy at the University of Oxford. His research is concentrated in the areas of chemical biology, enzymology, enzyme kinetics, drug discovery and cancer research.

• 1. Recombinant protein purification for structural and kinetic studiesMatthew Lloyd, Otsile Mojanaga and K Ravi Acharya2. Steady-state kinetic analysis of reversible enzyme inhibitorsMatthew Lloyd3. Steady-State Enzyme KineticsBharath Srinivasan4. Analysis of enzyme kinetic data using ICEKATBrian C. Smith5. NMR techniques in drug discoveryTim Woodman6. Dynamic simulations and pre-steady state kinetics to guide drug discoveryKen Johnson7. Design and assay of substrate-product analogues for racemases and epimerasesStephen L. Bearne8. Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugsRheem Totah9. Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugsRheem Totah10. Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosisSylvie Garneau-Tsodikova and Oleg Tsodikov11. Crystallographic fragment screening in academic cancer drug discoveryJane Endicott, Martin Noble and Mathew Martin12. Fast fragment- and compound-screening pipeline at the Swiss Light SourceJustyna A. Wojdyla, May E. Sharpe and Guenter Fritz13. Chemical biology, enzymology and drug discoveryKevin Dalby14. PROTACsMatthias Baud15. Proximity-Induced Pharmacology (PROTACs)Matthieu Schapira16. Chemo-enzymatic Labelling with asparaginyl endopeptidase (AEP)Louis Luk17. Development of 5-Aminolevulinic Acid Prodrugs for Photodynamic Therapy and PhotodiagnosisIan Eggleston18. Systems biology and single cell approachesUdo Opperman

Dr. Matthew Lloyd is a Senior Lecturer at Department of Pharmacy & Pharmacology, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio) of University of Bath, United Kingdom. He completed his Bachelor of Science at the University of Leicester, and his Doctor of Philosophy at the University of Oxford. His research is concentrated in the areas of chemical biology, enzymology, enzyme kinetics, drug discovery and cancer research.

• 1. Recombinant protein purification for structural and kinetic studiesMatthew Lloyd, Otsile Mojanaga and K Ravi Acharya2. Steady-state kinetic analysis of reversible enzyme inhibitorsMatthew Lloyd3. Steady-State Enzyme KineticsBharath Srinivasan4. Analysis of enzyme kinetic data using ICEKATBrian C. Smith5. NMR techniques in drug discoveryTim Woodman6. Dynamic simulations and pre-steady state kinetics to guide drug discoveryKen Johnson7. Design and assay of substrate-product analogues for racemases and epimerasesStephen L. Bearne8. Sensitive high throughput methods to screen for P450 inhibition: A- MI complex forming drugsRheem Totah9. Sensitive high throughput methods to screen for P450 inhibition: B-Heme loss causing drugsRheem Totah10. Discovery and development of inhibitors of acetyltransferase Eis to combat Mycobacterium tuberculosisSylvie Garneau-Tsodikova and Oleg Tsodikov11. Crystallographic fragment screening in academic cancer drug discoveryJane Endicott, Martin Noble and Mathew Martin12. Fast fragment- and compound-screening pipeline at the Swiss Light SourceJustyna A. Wojdyla, May E. Sharpe and Guenter Fritz13. Chemical biology, enzymology and drug discoveryKevin Dalby14. PROTACsMatthias Baud15. Proximity-Induced Pharmacology (PROTACs)Matthieu Schapira16. Chemo-enzymatic Labelling with asparaginyl endopeptidase (AEP)Louis Luk17. Development of 5-Aminolevulinic Acid Prodrugs for Photodynamic Therapy and PhotodiagnosisIan Eggleston18. Systems biology and single cell approachesUdo Opperman